Prostate-specific antigen (PSA) measurements' association with metastasis and mortality in patients with nmCRPC (non-metastatic castration resistant prostate cancer).

被引：1
|
作者：
Li, Sophia
Ding, Zhijie
Lin, Jennifer H.
Behl, Ajay S.
Pericone, Chris
Deshmukh, Siddhant
Macomson, Brian
Shore, Neal D.
机构：
[1] Janssen Sci Affairs LLC, Horsham, PA USA
[2] Janssen Sci Affairs LLC, Titusville, NJ USA
[3] Mu Sigma Business Solut Pvt Ltd, Bengaluru, India
[4] Carolina Urol Res Ctr, Myrtle Beach, SC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e17058
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17058
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Impact of prostate specific antigen doubling time on time to metastasis and overall survival in non-metastatic castration-resistant prostate cancer patients.
    Freedland, Stephen J.
    Ramaswamy, Krishnan
    Lechpammer, Stanislav
    Mardekian, Jack
    Schultz, Neil M.
    Huang, Ahong
    Wang, Li
    Baser, Onur
    George, Daniel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [12] Conceptual assessment of HRQOL among Japanese non-metastatic castration-resistant prostate cancer (nmCRPC) patients
    Nishimura, Kazuo
    Shiota, Masaki
    Eto, Masatoshi
    Satoh, Takefumi
    Stroupe, Angela
    Seo, Caroline
    Uzumcu, Alyssa
    Ledesma, Dianne Athene
    CANCER MEDICINE, 2023, 12 (02): : 1762 - 1778
  • [13] Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer
    Vlachostergios, Panagiotis J.
    Niaz, Muhammad Junaid
    Sun, Michael
    Mosallaie, Seyed Ali
    Thomas, Charlene
    Christos, Paul J.
    Osborne, Joseph R.
    Molina, Ana M.
    Nanus, David M.
    Bander, Neil H.
    Tagawa, Scott T.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [14] PREDICTORS OF TIME TO METASTASIS IN NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Moreira, Daniel
    Howard, Lauren
    Sourbeer, Katie
    Kundich, Robert
    Kane, Christopher
    Aronson, William
    Terris, Martha
    Cooperberg, Matthew
    Amling, Christopher
    Freedland, Stephen
    JOURNAL OF UROLOGY, 2014, 191 (04): : E921 - E921
  • [15] EFFECT OF ABIRATERONE ACETATE AND LOW DOSE PREDNISONE ON PROSTATE-SPECIFIC ANTIGEN IN PATIENTS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: THE RESULTS FROM IMPACT OF ABIRATERONE ACETATE IN PROSTATE-SPECIFIC ANTIGEN CORE STUDY
    Ryan, Charles J.
    Crawford, E. David
    Shore, Neal D.
    Underwood, Willie
    Wang, Jim
    DePalantino, Jannell
    Londhe, Anil
    Yang, Zane
    Black, Shawn
    McGowan, Tracy
    Kantoff, Philip W.
    JOURNAL OF UROLOGY, 2015, 193 (04): : E1091 - E1091
  • [16] Efficacy and safety of darolutamide in non-metastatic castration-resistant prostate cancer (nmCRPC) in the ARAMIS trial
    Pang, J. S-T.
    Shore, N.
    Smith, M. R.
    Tammela, T. L.
    Ulys, A.
    Vjaters, E.
    Polyakov, S.
    Jievaltas, M.
    Luz, M.
    Alekseev, B.
    Kuss, I.
    Le Berre, M-A.
    Snapir, A.
    Sarapohja, T.
    Fizazi, K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [17] Treatment Outcomes in Non-Metastatic Prostate Cancer Patients With Ultra-High Prostate-Specific Antigen
    Tai, Patricia
    Tonita, Jon
    Woitas, Carla
    Zhu, Tong
    Joseph, Kurian
    Skarsgard, David
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (04): : E525 - E530
  • [18] Non-metastatic castration-resistant Prostate Cancer Apalutamide delays Metastasis in Patients with MOCRPC
    Ruedesheim, Sabine M.
    VISCERAL MEDICINE, 2019, 35 (02) : 139 - 139
  • [19] Prognostic associations of early prostate-specific antigen (PSA) changes in patients with metastatic castration-resistant prostate cancer treated with with abiraterone acetate or enzalutamide
    Lopez Campos, F.
    Moreno, I.
    Conde-Moreno, A.
    Gomez-Iturriaga, A.
    Ruiz Vico, M.
    Romero Laorden, N.
    Henriquez Lopez, I.
    Peleteiro Higuero, P.
    Lozano Mejorada, R.
    Piquer, T.
    Couselo, M.
    Gomez Ramos, J.
    Navarro, J.
    Barrionuevo Castillo, P.
    Garcia, R.
    Villatoro, R.
    Montesa, A.
    Saez, M. I.
    Herrera, B.
    Castro Marcos, E.
    ANNALS OF ONCOLOGY, 2018, 29 : 285 - 285
  • [20] Prostate-Specific Membrane Antigen-Directed Therapy for Metastatic Castration-Resistant Prostate Cancer
    Teo, Min Yuen
    Morris, Michael J.
    CANCER JOURNAL, 2016, 22 (05): : 347 - 352
12345